Forum topic

3 posts / 0 new
Last post
Peter Marino
safe administration of vancomycin through a novel midline catheter a randomized prospective clinical trial

http://www.vascular-access.info/article/safe-administration-of-vancomycin-through-a-novel-midline-catheter--a-randomized--prospective-clinical-trial

 

Well...  here we go, the NY metro area is now infusing Vanco through midlines as per a 22 Pt. trial.

Jose Delp RN BSN
safe administation of vancomycin through a novel midline cathete

Wow! I am sorry to see this published. Reading the article I have more than a dozen questions.... First of course is how did they verify there was no thrombosis..... I could go on asnd on though.

Jose Delp RN BSN VA-BC

jill nolte
my question

So the New York metro area changed policy based on an article?  That seems hasty, the guidelines have not changed.   Most definitely this "vanc through a midline" is not resolved with this study.  If it's safe to infuse a diluted vanc through a midline it would be safer to infuse a diluted vanc through a piv.  If truly the diluted vanc isn't irritating the piv should be able to dwell until symptomatic, am I right?  

The signs and symptoms of phlebitis/infiltration should be SO much easier to detect in a peripheral vs a midline.  Observable symptoms of tightness, swelling, redness are easier to assess in a piv.  Patient reportable symptoms of pain, burning, tightness could well be masked with pain medications or general illness.

In my opinion this vanc through a midline is a bad idea and I'm sorry to see this article out to confuse those less knowledgable of sound vascular access practice. 

Log in or register to post comments